Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Carmell Co. stock logo
CTCX
Carmell
$2.70
-4.6%
$3.01
$0.17
$1.27
$56.44M0.514.65 million shs20,694 shs
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
$1.06
-11.7%
$1.06
$0.71
$1.61
$66.53M1.19192,541 shs170,505 shs
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
$1.28
+6.7%
$1.08
$0.40
$1.65
$16.15M2.3925,543 shs231,677 shs
Spectral AI, Inc. stock logo
MDAI
Spectral AI
$2.23
-5.5%
$2.39
$0.82
$3.25
$56.46M0.9540,872 shs853,593 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Carmell Co. stock logo
CTCX
Carmell
0.00%-4.59%+0.75%+2,025.98%+157.14%
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
+20.00%+31.71%+13.21%+37.93%+14.29%
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
+7.62%-8.40%0.00%+114.29%+22.45%
Spectral AI, Inc. stock logo
MDAI
Spectral AI
-3.28%-2.48%-17.48%+66.20%+56.29%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Carmell Co. stock logo
CTCX
Carmell
N/AN/AN/AN/AN/AN/AN/AN/A
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
1.6258 of 5 stars
3.32.00.00.02.00.00.6
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
2.5184 of 5 stars
3.53.00.00.02.91.70.0
Spectral AI, Inc. stock logo
MDAI
Spectral AI
1.8394 of 5 stars
3.52.00.00.00.03.30.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Carmell Co. stock logo
CTCX
Carmell
0.00
N/AN/AN/A
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
2.50
Moderate Buy$5.50400.00% Upside
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
3.00
Buy$2.0062.60% Upside
Spectral AI, Inc. stock logo
MDAI
Spectral AI
3.00
Buy$3.5059.09% Upside

Current Analyst Ratings Breakdown

Latest IINN, MDAI, CTCX, and CTSO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/8/2025
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00
7/21/2025
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00
6/25/2025
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00
6/2/2025
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
Litchfield Hills Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy
6/2/2025
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
Litchfield Hills Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy$2.00
5/15/2025
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00 ➝ $10.00
5/15/2025
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$1.00 ➝ $1.00
(Data available from 8/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Carmell Co. stock logo
CTCX
Carmell
$32.84K1,718.79N/AN/A$1.07 per share2.52
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
$35.60M1.94N/AN/A$0.20 per share5.50
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
N/AN/AN/AN/A$0.34 per shareN/A
Spectral AI, Inc. stock logo
MDAI
Spectral AI
$29.58M1.88N/AN/A($0.32) per share-6.88
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Carmell Co. stock logo
CTCX
Carmell
-$15.44MN/A0.00N/AN/A-217.50%-50.22%N/A
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
-$20.72M-$0.17N/AN/AN/A-25.58%-109.15%-28.90%N/A
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
-$11.05MN/A0.00N/AN/AN/AN/AN/A
Spectral AI, Inc. stock logo
MDAI
Spectral AI
-$15.31M-$0.54N/AN/AN/A-30.75%N/A-11.37%8/12/2025 (Estimated)

Latest IINN, MDAI, CTCX, and CTSO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2025Q2 2025
Spectral AI, Inc. stock logo
MDAI
Spectral AI
-$0.07N/AN/AN/A$5.44 millionN/A
8/7/2025Q2 2025
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
-$0.07-$0.05+$0.02$0.03$9.79 million$9.62 million
5/14/2025Q1 2025
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
-$0.08-$0.06+$0.02-$0.02$9.01 million$8.73 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Carmell Co. stock logo
CTCX
Carmell
N/AN/AN/AN/AN/A
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
N/AN/AN/AN/AN/A
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
N/AN/AN/AN/AN/A
Spectral AI, Inc. stock logo
MDAI
Spectral AI
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Carmell Co. stock logo
CTCX
Carmell
N/A
0.31
0.29
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
0.98
2.61
2.30
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
0.09
2.02
1.89
Spectral AI, Inc. stock logo
MDAI
Spectral AI
N/A
1.41
1.37

Institutional Ownership

CompanyInstitutional Ownership
Carmell Co. stock logo
CTCX
Carmell
24.22%
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
32.87%
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
12.72%
Spectral AI, Inc. stock logo
MDAI
Spectral AI
67.08%

Insider Ownership

CompanyInsider Ownership
Carmell Co. stock logo
CTCX
Carmell
29.00%
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
6.60%
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
29.40%
Spectral AI, Inc. stock logo
MDAI
Spectral AI
30.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Carmell Co. stock logo
CTCX
Carmell
1420.91 million14.84 millionNot Optionable
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
22062.76 million58.62 millionOptionable
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
2012.62 million8.91 millionNot Optionable
Spectral AI, Inc. stock logo
MDAI
Spectral AI
8325.32 million17.55 millionNot Optionable

Recent News About These Companies

Spectral AI (NASDAQ:MDAI) Trading Up 1.7% - Should You Buy?
MDAI: DeepView De Novo Submission
Spectral AI, Inc. (MDAI) - Yahoo Finance
Spectral Ai Inc Share Chat (MDAI.US)
What's Next: Spectral AI's Earnings Preview

New MarketBeat Followers Over Time

Media Sentiment Over Time

Carmell stock logo

Carmell NASDAQ:CTCX

$2.70 -0.13 (-4.59%)
As of 08/8/2025

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. In addition, the company is also developing a line of men's products and a line of topical haircare products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Therapeutics Corporation and changed its name to Carmell Corporation in November 2023. Carmell Therapeutics Corporation was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.

Cytosorbents stock logo

Cytosorbents NASDAQ:CTSO

$1.06 -0.14 (-11.67%)
Closing price 04:00 PM Eastern
Extended Trading
$1.06 +0.00 (+0.47%)
As of 05:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally. Its flagship product is CytoSorb, an extracorporeal cytokine adsorber for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention, and treatment of perioperative complications, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant; and offers VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals. The company also develops CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, and removal of anti-A and anti-B blood group antibodies from whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it develops BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; DrugSorb, a device to remove drugs and chemicals from the blood; and DrugSorb-ATR, an antithrombotic removal system. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey.

Inspira Technologies OXY B.H.N. stock logo

Inspira Technologies OXY B.H.N. NASDAQ:IINN

$1.28 +0.08 (+6.67%)
Closing price 04:00 PM Eastern
Extended Trading
$1.21 -0.07 (-5.16%)
As of 04:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.

Spectral AI stock logo

Spectral AI NASDAQ:MDAI

$2.23 -0.13 (-5.51%)
Closing price 04:00 PM Eastern
Extended Trading
$2.16 -0.07 (-3.32%)
As of 05:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas.